logo
Sign in

SANOFI CONS HEALTHC IND L (SANOFICONR) financials

SANOFI CONS HEALTHC IND L (SANOFICONR) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products.[2]

  • Market Cap: ₹8,173Cr.
  • Current Price: ₹3,549
  • Stock P/E: 30.7
  • ROE: 71.6%
  • ROCE: 89.9%
  • Book Value: ₹151
  • Dividend Yield: 2.11%
  • 52W High / Low: ₹5,255/3,525

In Jun 2026, SANOFI CONS HEALTHC IND L (SANOFICONR) reported sales ₹236 Cr and net profit ₹69 Cr.

Annual TTM: sales ₹950 Cr, net profit ₹266 Cr.

Shareholding: Promoters 71.27% (Jun 2026), FIIs 2.60% (Jun 2026), DIIs 17.85% (Jun 2026), Public 8.28% (Jun 2026), No. of Shareholders 47,511% (Jun 2026).

SANOFICONR quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales160171173221234251229236
Expenses97109109151149161140146
Operating Profit6362647085908989
OPM %39%36%37%32%36%36%39%38%
Other Income325123566
Interest30001000
Depreciation21233333
Profit before tax6163677984909192
Tax %26%29%25%23%25%27%25%25%
Net Profit4544506163666869
EPS in Rs19.5419.2421.7126.3627.3128.8729.4429.87
Raw PDF————————
SANOFICONR profit and loss (₹ Cr.)
CategoryDec 2023 8mDec 2024Mar 2025Dec 2025TTM
Sales555724878878950
Expenses337454569569597
Operating Profit219271309309353
OPM %39%37%35%35%37%
Other Income2-15252520
Interest04222
Depreciation24121213
Profit before tax219247320320357
Tax %25%27%25%25%—
Net Profit165181240240266
EPS in Rs—78.59104.25104.25115.49
Dividend Payout %6%70%0%72%—
SANOFICONR balance sheet (₹ Cr.)
CategoryDec 2023Dec 2024Dec 2025Jun 2026
Equity Capital2232323
Reserves206250361325
Borrowings0202521
Other Liabilities138138138338
Total Liabilities345431547706
Fixed Assets5293630
CWIP3100
Investments0000
Other Assets338402511677
Total Assets345431547706
SANOFICONR cash flows (₹ Cr.)
CategoryDec 2023Dec 2024Mar 2025Dec 2025
Cash from Operating Activity-0439—175
Cash from Investing Activity02—8
Cash from Financing Activity2-116—-134
Net Cash Flow2325—48
Free Cash Flow-4429—167
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit2%208%—85%
SANOFICONR shareholding pattern (%)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters60.40%60.40%60.40%71.27%71.27%71.27%71.27%71.27%
FIIs5.22%4.42%4.52%3.24%2.94%2.83%2.76%2.60%
DIIs23.83%25.35%25.48%16.89%17.21%17.33%17.57%17.85%
Public10.56%9.84%9.59%8.59%8.58%8.57%8.41%8.28%
No. of Shareholders58,58255,73451,85949,63248,80848,07548,41847,511
SANOFICONR key ratios
CategoryDec 2023Dec 2024Mar 2025Dec 2025
Debtor Days217—12
Inventory Days23280—98
Days Payable144138—126
Cash Conversion Cycle109-51—-16
Working Capital Days134-33—-4
ROCE %—111%—90%
SANOFICONRUpdated 18 Oct 2026, 17:08

Sanofi Cons Healthc Ind L

Market Cap

₹8,173Cr.

Current Price

₹3,549

High / Low

₹5,255/3,525

Stock P/E

30.7

ROE71.6%
ROCE89.9%
Book Value₹151
Face Value₹10.0
Dividend Yield2.11%

About

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products.[2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryDec 2023Dec 2024Mar 2025Dec 2025
Debtor Days217—12
Inventory Days23280—98
Days Payable144138—126
Cash Conversion Cycle109-51—-16
Working Capital Days134-33—-4
ROCE %—111%—90%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SANOFI CONS HEALTHC IND L (SANOFICONR)?

The reported market capitalisation for SANOFI CONS HEALTHC IND L (SANOFICONR) is ₹8,173Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SANOFICONR?

The current price shown for SANOFI CONS HEALTHC IND L (SANOFICONR) on Fincrux is ₹3,549 with a 52-week high/low of ₹5,255/3,525.

What is the P/E ratio of SANOFI CONS HEALTHC IND L (SANOFICONR)?

The stock P/E for SANOFI CONS HEALTHC IND L (SANOFICONR) is 30.7 on Fincrux, with ROE at 71.6% and ROCE at 89.9%.

What were SANOFICONR latest quarterly results?

For Jun 2026, SANOFI CONS HEALTHC IND L (SANOFICONR) reported sales ₹236 Cr and net profit ₹69 Cr (figures in ₹ crore unless noted).

What are SANOFICONR annual sales and net profit?

For TTM, SANOFI CONS HEALTHC IND L (SANOFICONR) shows sales of ₹950 Cr and net profit of ₹266 Cr on the Fincrux profit & loss statement.

Who owns SANOFI CONS HEALTHC IND L (SANOFICONR)?

Latest shareholding for SANOFI CONS HEALTHC IND L (SANOFICONR) on Fincrux: Promoters 71.27% (Jun 2026), FIIs 2.60% (Jun 2026), DIIs 17.85% (Jun 2026), Public 8.28% (Jun 2026), No. of Shareholders 47,511% (Jun 2026).

Where can I find SANOFI CONS HEALTHC IND L (SANOFICONR) financials?

SANOFI CONS HEALTHC IND L (SANOFICONR) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SANOFICONR balance sheet and cash flow?

Yes. The SANOFI CONS HEALTHC IND L (SANOFICONR) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 17:08

Designed & Shipped by Harshit Bansal